UBS Group’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,267
| Closed | -$13.7K | – | 8874 |
|
|
2023
Q2 | $13.7K | Buy |
5,267
+442
| +9% | +$1.15K | ﹤0.01% | 5959 |
|
|
2023
Q1 | $8.78K | Buy |
+4,825
| New | +$8.78K | ﹤0.01% | 6604 |
|
|
2022
Q4 | – | Sell |
-34,809
| Closed | -$67K | – | 10009 |
|
|
2022
Q3 | $67K | Buy |
34,809
+5,473
| +19% | +$10.5K | ﹤0.01% | 5010 |
|
|
2022
Q2 | $88K | Sell |
29,336
-2,345
| -7% | -$7.03K | ﹤0.01% | 4531 |
|
|
2022
Q1 | $120K | Sell |
31,681
-2,930
| -8% | -$11.1K | ﹤0.01% | 4769 |
|
|
2021
Q4 | $394K | Buy |
34,611
+34,192
| +8,160% | +$389K | ﹤0.01% | 4161 |
|
|
2021
Q3 | $7K | Sell |
419
-31
| -7% | -$518 | ﹤0.01% | 7202 |
|
|
2021
Q2 | $10K | Buy |
+450
| New | +$10K | ﹤0.01% | 6968 |
|